GLT1 is one of the major transporters responsible for maintenance of glutamate homeostasis in the brain. In the present study, glutamate transporter 1-deficient GLT1 homozygous (-/-) and heterozygous (+/-) mice were investigated with the intention that they may provide a model of hyperglutamatergic state resulting in various behavioral alterations. The GLT1 (-/-) mice had lower body and brain weight, mild neuronal loss in CA1 hippocampal region as well as focal gliosis and severe focal neuronal paucity in layer II of the neocortex. The short life-span of GLT1 (-/-) precluded us from systematic behavioral studies in these mice. In contrast, GLT1 (+/-) mice exhibiting a 59% decrease in GLT1 immunoreactivity in their brain tissue, showed no apparent morphological brain abnormalities, and their life-span was not markedly different from controls. Behavior ally, GLT1 (+/-) presented moderate behavioral alterations compared to their wildtype littermates, such as: mild sensorimotor impairment, hyperlocomotion (at 3 month of age only), lower anxiety (at 6 months), better learning of cue-based fear conditioning but worse context-based fear conditioning. Our results suggest that GLT1 (+/-) mice may serve as a potentially useful model to study neurodegenerative disease conditions with mild hyperglutamatergic activity.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Accili D, CS Fishburn, J Drago, H Steiner, JE Lachowicz, BH Park, EB Gauda, EJ Lee, MH Cool, DR Sibley, CR Gerfen, H Westphal and S Fuchs (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proc. Natl. Acad. Sci. USA 93, 1945–1949.
Benveniste H, J Drejer, A Schusboe and NH Diemer (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis.J. Neurochem. 43, 1369–1374.
Carlsson M and A Carlsson (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson’s disease.Trends Neurosci. 13, 272–276.
Collingridge G (1987) The role of NMDA receptors in learning and memory.Nature 330, 604–605.
Czuczwar SJ and BS Meldrum (1982) Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acd.Eur. J. Pharmacol. 83, 335–338.
Danbolt NC (2001) Glutamate uptake.Prog. Neurobiol. 65, 1–105.
Danysz W and CG Parsons (2002) Neuroprotective potential of ionotropic glutamate receptor antagonists - II.Neurotox. Res. 4, 119–126.
Danysz W and CG Parsons (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease. Preclinical evidence.Intl. J. Geriatric Psychiatry 18, S23-S32.
Danysz W, CG Parsons, I Bresink and G Quack (1995a) Glutamate in CNS disorders — a revived target for drug development.Drug News Perspect. 8, 261–277.
Danysz W, W Zajaczkowski and CG Parsons (1995b) Modulation of learning processes by ionotropic glutamate receptor ligands.Behav. Pharmacol. 6, 455–474.
Eilam D, M Dank and R Maurer (2003) Voles scale locomotion to the size of the open-field by adjusting the distance between stops: a possible link to path integration.Behav. Brain Res. 141, 73–81.
Fradley RL, GF O’Meara, RJ Newman, A Andrieux, D Job and DS Reynolds (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating.Behav. Brain Res. 163, 257–264.
Gravius A, C Barberi, D Schäfer, WJ Schmidt and W Danysz (2006) The role of groupI metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats — a comparison.Neuropharmacology 51, 1146–1155.
Greenamyre JT (1991) Neuronal bioenergetic defects, excitotoxicity and Alzheimer’s disease — use it and lose it.Neurobiol. Aging 12, 334–336.
Greenamyre JT, EF Maragos, RL Albin, JB Penney and AB Young (1988) Glutamate transmission and toxicity in Alzheimer’s disease.Prog. Neuro-Psych. Biol. Psychiatry 12, 421–430.
Harris ME, YN Wang, NW Pedigo, K Hensley, DA Butterfield and JM Carney (1996) Amyloid-β peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cul tures.J. Neurochem. 67, 277–286.
Katagiri H, K Tanaka and T Manabe (2001) Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction.Eur. J. Neurosci. 14, 547–553.
Li JH, YH Wang, BB Wolfe, KE Krueger, L Corsi, G Stocca and S Vicini (1998) Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical.Eur. J. Neurosci. 10, 1704–1715.
Lipton SA (1992) Models of neuronal injury in AIDS-another role for the NMDA receptor.Trends Neurosci. 15, 75–79.
Masliah E, M Alford, R DeTeresa, M Mallory and L Hansen (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease.Ann. Neurol. 40, 759–766.
Masliah E, M Alford, M Mallory, E Rockenstein, D Moechars and F Van Leuven (2000) Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice.Exp. Neurol. 163, 381–387.
Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders.Neurology 44, 14–23.
Meldrum B and J Garthwaite (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease.Trends Pharmacol. Sci. 11, 379–387.
Mitani A and K Tanaka (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: anin vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1.J. Neurosci. 23, 7176–82.
Nicolls D and D Attwell (1990) The release and uptake of exitatory amino acid.Trends Pharmacol. Sci. 11, 462–468.
Noda M, H Nakanishi and N Akaike (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-β peptide.Neuroscience 92, 1465–1474.
Pardo AC, V Wong, LM Benson, M Dykes, K Tanaka, JD Rothstein and NJ Maragakis (2006) Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.Exp. Neurol. 201(1), 120–130. Epub 2006 Jun 6.
Phillips RG and JE LeDoux (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.Behav. Neurosci. 106, 274–285.
Rothman SM and JW Olney (1987) Excitotoxicity and the NMDA receptor.Trends Neurosci. 10, 299–302.
Rothstein JD (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.Clin. Neurosci. 3, 348–359.
Rothstein JD, LJ Martin and RW Kuncl (1992) Decreased gluta mate transport by the brain and spinal cord in amyotrophic lateral sclerosis.N. Engl. J. Med. 326, 1464–1468.
Rothstein JD, M Vankammen, AI Levey, LJ Martin and RW Kuncl (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.Ann. Neurol. 38, 73–84.
Schmidt WJ, M Bubser and W Hauber (1990) Excitatory amino acids and Parkinson’s disease.Trends Neurosci. 13, 46.
Schwarcz R and C Köhler (1983) Differential vulnerability of central neurons of the rat to quinolinic acid.Neurosci. Lett. 38, 85–90.
Seal RP and SG Amara (1999) Excitatory amino acid transporters: a family in flux.Annu. Rev. Pharmacol. Toxicol. 39, 431–456.
Steiner H, S Fuchs and D Accili (1997) D3 dopamine receptor- deficient mouse: evidence for reduced anxiety.Physiol. Behav.63, 137–141.
Takatsuru Y, M Iino, K Tanaka and S Ozawa (2007) Contribution of glutamate transporter GLT-1 to removal of synaptically released glutamate at climbing fiber-Purkinje cell synapses.Neurosci. Lett. 420, 85–89.
Tanaka K (1993) Expression cloning of a rat glutamate transporter.Neurosci. Res. 16, 149–153.
Tanaka K (2000) Functions of glutamate transporters in the brain.Neurosci. Res. 37, 15–19.
Tanaka K, K Watase, T Manabe, K Yamada, M Watanabe, K Takahashi, H Iwama, T Nishikawa, N Ichihara, T Kikuchi, S Okuyama, N Kawashima, S Hori, M Takimoto and K Wada (1997a) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.Science 276, 1699–1702.
Tanaka E, S Yamamoto, Y Kudo, S Mihara and H Higashi (1997b) Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neuronsin vitro.J. Neurophysiol. 78, 891–902.
Turski L, K Bressler, KJ Rettig, PA Löschmann and H Wachtel (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.Nature 349, 414–417.
Ueda Y, T Doi, N Tsuru, J Tokumaru and Y Mitsuyama (2002) Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice.Brain Res. Mol. Brain Res. 104, 120–126.
Zoia C, T Cogliati, E Tagliabue, G Cavaletti, G Sala, G Galimberti, I Rivolta, V Rossi, L Frattola and C Ferrarese (2004) Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease.Neurobiol. Aging 25, 149–157.
About this article
Cite this article
Kiryk, A., Aida, T., Tanaka, K. et al. Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction. neurotox res 13, 19–30 (2008). https://doi.org/10.1007/BF03033364
- GLT1 KO mice
- GLT1 (+/-) mice
- Glutamate uptake